Makers Laboratories (NSE:MAKERSL) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAKERSL Makers Laboratories Ltd NSE:MAKERSL
55 GF Score
Price ₹198.73
GF Value ₹185.04
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Makers Laboratories Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

NSE:MAKERSL
55GF Score
Makers Laboratories Ltd NSE:MAKERSL
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Makers Laboratories (NSE:MAKERSL) Overvalued in 2026?

Based on GuruFocus' analysis, Makers Laboratories stock appears to be overvalued. The current stock price of ₹198.73 is trading 7.4% above its estimated GF Value™ of ₹185.04. GuruFocus considers Makers Laboratories to be Fairly Valued.

Key valuation signals for NSE:MAKERSL:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹185.04 vs. price of ₹198.73 (7.4% above fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the NSE:MAKERSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Makers Laboratories Business Description

Other Exchanges 506919:India
Address 54-D, Kandivli Industrial Estate, Charkop, Kandivali (West), Mumbai, MH, IND, 400067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough Range), and Exylin (Amoxycillin range), among others. The reportable segment of the company is the Pharmaceutical segment.
55GF Score

Get the complete analysis for NSE:MAKERSL

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹198.73
Price
₹185.04
GF Value